ABSTRACT
The circadian clock controls the phosphorylation and activity of eukaryotic translation initiation factor 2α (eIF2α). In Neurospora crassa, the clock drives a daytime peak in the activity of the eIF2α kinase CPC-3, the homolog of yeast and mammalian GCN2 kinase. This leads to increased levels of phosphorylated eIF2α (P-eIF2α) and reduced mRNA translation initiation during the day. We hypothesized that rhythmic eIF2α activity also requires dephosphorylation of P-eIF2α at night by phosphatases. In support of this hypothesis, we show that mutation of N. crassa PPP-1, a homolog of the yeast eIF2α phosphatase GLC7, leads to high and arrhythmic P-eIF2α levels, while maintaining core circadian oscillator function. PPP-1 levels are clock-controlled, peaking in the early evening, and rhythmic PPP-1 levels are necessary for rhythmic P-eIF2α accumulation. Deletion of the N terminus of N. crassa eIF2γ, the region necessary for eIF2γ interaction with GLC7 in yeast, led to high and arrhythmic P-eIF2α levels. These data supported that N. crassa eIF2γ functions to recruit PPP-1 to dephosphorylate eIF2α at night. Thus, in addition to the activity of CPC-3 kinase, circadian clock regulation of eIF2α activity requires dephosphorylation by PPP-1 phosphatase at night. These data show how the circadian clock controls the activity a central regulator of translation, critical for cellular metabolism and growth control, through the temporal coordination of phosphorylation and dephosphorylation events.
KEYWORDS: eIF2α, PPP-1, phosphatase, translation initiation, circadian clock, eIF2γ, Neurospora crassa
INTRODUCTION
The endogenous circadian clock is a conserved mechanism that allows organisms to anticipate daily environmental changes to maximize fitness (1–4). As such, it is linked to environmental sensing pathways that monitor external light, temperature, and nutrient availability. These input pathways provide information to modulate the clock. In turn, the clock utilizes feedback loops to sustain endogenous molecular oscillations and to generate rhythms in downstream output pathways, even in the absence of external cues (5–10). One of the most studied output pathways is rhythmic transcription, with up to 50% of the eukaryotic genome regulated by clock at the transcriptional level (9, 11–17). Furthermore, several transcript-modifying processes (including mRNA capping, splicing, polyadenylation, and deadenylation) are under clock control (11, 18–21). While mRNA rhythms contribute to the generation of rhythmic protein abundance, approximately 40 to 50% of rhythmic proteins in both mouse liver and in the fungus N. crassa derive from mRNAs that are not rhythmic (22–25), suggesting circadian regulation of protein stability and/or mRNA translation. In support of clock control of mRNA translation, the expression and/or phosphorylation of several translation factors are rhythmic in eukaryotic cells (22, 26–28), including rhythms in the phosphorylation and activity of the highly conserved translation initiation factor eIF2α (29–31). Interestingly, many of the proteins in this class (rhythmic protein, arrhythmic mRNA) revealed a metabolic time of day partitioning, with daytime peaks in proteins involved in catabolism or energy utilization and nighttime peaks in anabolism or energy storage (25). These findings support that clock control of translation impacts the metabolic state of the cell. Thus, understanding the connection between the clock and control of the energetically expensive process of translation is crucial for a complete understanding of cellular growth control.
How the clock controls translation is just beginning to be unraveled, with recent studies revealing a conserved role for the clock in control of translation initiation (29–31). Translation initiation starts with the formation of the ternary complex, which contains initiation factor eIF2, composed of α, β and γ subunits, Met-tRNAiMet and GTP (32, 33). There are multiple steps in the process, but initiation ends and elongation begins when eIF5 mediates the hydrolysis of GTP-eIF2α to GDP-eIF2α, which along with the other initiation factors, dissociates and allows 40S- and 60S-ribosomal subunit joining to create the translation-competent 80S ribosome (34, 35). To initiate another round of translation, the guanine nucleotide exchange factor (GEF) eIF2B must charge GDP-eIF2α with GTP in a recycling step that is critical for controlling overall translation rates (32, 33). Ser51 phosphorylated eIF2α (P-eIF2α) inhibits eIF2B GEF activity by competitively binding to the limiting eIF2B (33), thus leading to reduced translation initiation of many mRNAs (32, 33), while also promoting translation of mRNAs with special motifs, including upstream ORFs (uORFs) (36). The levels of P-eIF2α have been correlated with cell growth, cancer, memory and learning and are stimulated by the integrated stress response (ISR) and the mammalian target of rapamycin (mTOR) pathways (37–39). In mammals (29, 30) and N. crassa (31), the circadian clock controls rhythms in P-eIF2α abundance. Thus, studies examining the interplay between the clock and the known input pathways will help reveal the full range of translational regulation by eIF2α phosphorylation.
The mechanism of clock control of eIF2α phosphorylation is currently best understood in the fungus N. crassa where the activity of the ISR responsive kinase CPC-3 (the homolog of yeast/mammalian GCN2) is thought to be modulated at different times of day via GCN1-dependent delivery of rhythmic levels of uncharged tRNAs (31). CPC-3 is required for Ser51 phosphorylation of eIF2α (P-eIF2α), and hyperactivation of CPC-3 kinase activity, either by pharmacological induction (3-AT) or by a constitutively active mutation (cpc-3c), abolished P-eIF2α rhythms. However, it is not known whether CPC-3 is sufficient to drive rhythms in P-eIF2α accumulation (31). In particular, we were interested in learning how P-eIF2α is converted back to the initiation competent dephosphorylated eIF2α and whether a phosphatase might also contribute to the daily rhythms in eIF2α activity.
Protein phosphatase 1 (PP1) dephosphorylates eIF2α in yeast (40) and mammalian (41) cells. This activity requires the catalytic subunit GLC7 in yeast, as well as PP1α, PP1β, or PP1γ isoforms in mammalian cells, and also requires one or more noncatalytic regulatory subunits to target PP1 to P-eIF2α (42). In mammalian cells, the RVxF motif present on GADD34 (PPP1R15A) and CReP (PPP1R15B) recruits PP1 to dephosphorylate Ser51 on eIF2α (43, 44). GADD34 and/or CReP homologs are present in chickens, frogs, and zebrafish, and a degenerate ortholog was identified in Drosophila (45). In yeast cells, however, there is no GADD34 or CReP homolog, but instead, an N-terminal extension of eIF2γ contains an RVxF motif that recruits GLC7 to dephosphorylate Ser51 of eIF2α (45). N. crassa PPP-1 (NCU00043) is the homolog of yeast GLC7 and is essential for survival (46). PPP-1 was previously shown to dephosphorylate FRQ protein to regulate the pace of the circadian clock (47). However, it was not known whether PPP-1 also functions to dephosphorylate P-eIF2α and control rhythmic eIF2α activity in N. crassa. In this study, we show that dephosphorylation of eIF2α in vitro required PPP-1, that PPP-1 levels are clock-controlled with a peak during the subjective night, and that the rhythm in PPP-1 accumulation is necessary for cycling P-eIF2α levels. Our study further revealed that the N terminus of eIF2γ, which lacks a consensus RVxF motif, is required to recruit PPP-1 to dephosphorylate eIF2α and maintain robust P-eIF2α rhythmicity but is not required to maintain circadian clock function.
RESULTS
PPP-1 phosphatase reduces P-eIF2α levels.
To determine whether phosphatase PPP-1 regulates the levels of P-eIF2α in N. crassa, the levels and phosphorylation status of eIF2α were examined in ppp-1RIP mutant cells (47) from cultures grown in constant dark (DD) and harvested at 28 h (subjective night), which represents the low point of P-eIF2α abundance in wild-type (WT) cells (31) (Fig. 1A). P-eIF2α levels were significantly higher in ppp-1RIP mutant cells compared to WT cells harvested at 28 h, as well as in cells harvested in the subjective morning (DD40) (see Fig. S1A in the supplemental material) or grown in constant light (LL) (see Fig. S1B). The ppp-1RIP mutant was previously shown in vitro to reduce PPP-1 activity on P-phosphorylase by ∼70% (47). P-eIF2α abundance was ∼2-fold higher in ppp-1RIP cells compared to WT cells, suggesting that PPP-1 promotes the dephosphorylation of P-eIF2α. The abundance of total eIF2α was not altered in the ppp-1RIP cells (Fig. 1A). Complementation of ppp-1RIP cells with a WT copy of ppp-1 inserted into the csr-1 locus (ppp-1RIP; csr-1::ppp-1) reduced P-eIF2α levels to back to WT levels (Fig. 1A). These data support a role for PPP-1 in maintaining the low levels of P-eIF2α present at subjective night.
To determine whether changes in PPP-1 protein abundance can control P-eIF2α levels, ppp-1 was put under the control of the copper regulatable Ptcu-1 promoter (48), and PPP-1 levels were detected using a PPP-1-specific antibody (see Fig. S2A). Consistent with the idea that PPP-1 controls P-eIF2α levels in vivo, copper sulfate (Cu) repression of Ptcu-1::ppp-1 led to low PPP-1 protein expression and high P-eIF2α levels. Conversely, addition of the copper chelator bathocuproinedisulfonic acid (BCS), led to high PPP-1 protein expression and low P-eIF2α levels compared to the control (U, untreated) (Fig. 1B). No significant changes were observed in eIF2α levels in any of the conditions used. Together, these data support the idea that PPP-1 either directly and/or indirectly reduces P-eIF2α levels in N. crassa.
To determine whether PPP-1 is responsible for dephosphorylating P-eIF2α, the eIF2 complex was purified from N. crassa cells containing a C-terminal V5-tagged eIF2γ (eIF2γ::v5) by coimmunoprecipitation with anti-V5 antibody (see Fig. S2B). To test whether there is a stable association of PPP-1 phosphatase with the eIF2 complex, we first examined P-eIF2α levels over time from the immunoprecipitated complex without addition of cell extract (Mock). We found that P-eIF2α levels in the mock treatments were unchanged over time, suggesting that PPP-1, or other phosphatases, were not copurified in the eIF2 complex (see Fig. S2C). Consistent with these data, PPP-1 was not detected in the eIF2 complex using anti-PPP-1 antibody in Western blots. To examine whether addition of PPP-1 can dephosphorylate P-eIF2α in the eIF2 complex, total protein extracts containing endogenous PPP-1 from subjective evening (DD28) cells were added. To avoid potential rephosphorylation by the CPC-3 kinase, we utilized Δcpc-3 extracts (Fig. 1C). Cell extracts deficient in PPP-1 (ppp-1RIP; Δcpc-3) were also examined (Fig. 1C). Extracts from Δcpc-3 cells led to an ∼50% reduction of P-eIF2α levels after 120 min, while no significant dephosphorylation of eIF2α was detected using extracts from ppp-1RIP; Δcpc-3 cells despite the ppp-1RIP mutant retaining some activity. These data suggested that the residual PPP-1 activity in the ppp-1RIP mutant is not sufficient to dephosphorylate P-eIF2α at a level that is detectable in in vitro assays. Taken together, these data support that in vitro dephosphorylation of P-eIF2α depends on the transient presence of PPP-1.
In S. cerevisiae, activation of the eIF2α kinase GCN2 in vivo requires its association with ribosomes (49). Uncharged tRNAs are transferred from the ribosome to GCN2 by GCN1 to activate GCN2 (50–53). We found that N. crassa PPP-1 associates with ribosomes (see Fig. S2D), suggesting the possibility that this interaction may facilitate direct access to its substrate P-eIF2α. Taken together, these results support the idea that PPP-1 promotes P-eIF2α dephosphorylation and are consistent with PPP-1 directly dephosphorylating eIF2α.
PPP-1 phosphatase is required for clock control of P-eIF2α levels.
To determine whether PPP-1 phosphatase controls rhythmic P-eIF2α levels in N. crassa, the phosphorylation status of eIF2α was examined in WT and ppp-1RIP cells grown in a circadian time course (Fig. 2). In WT cells, P-eIF2α, but not total eIF2α levels, were rhythmic, with a peak in the subjective late morning (Fig. 2A and B), consistent with our previous studies (31). While P-eIF2α and total eIF2α levels fluctuated in ppp-1RIP cells, P-eIF2α rhythms were abolished (Fig. 2C and D). Because the circadian clock was previously shown to be functional in ppp-1RIP cells (47), it seemed unlikely that P-eIF2α rhythms were abolished due to a clock defect in these cells. However, to confirm clock function in the mutant, FRQ::LUC protein rhythms were examined in WT and ppp-1RIP cells. Consistent with published data (47), FRQ levels oscillated robustly in ppp-1RIP cells, but with an ∼2 h shorter period compared to WT cells (Fig. 2E). Taken together, these data support the idea that the loss of P-eIF2α rhythms in ppp-1RIP cells is not due to loss of rhythmicity of the core oscillator, but instead results from disruption of downstream circadian regulation of P-eIF2α levels.
Deletion of the N terminus of eIF2γ alters eIF2α phosphorylation levels and the dephosphorylation rate of eIF2α in vitro.
The N terminus of N. crassa eIF2γ (NCU02810) resembles the N terminus of the S. cerevisiae eIF2γ in that it has an 80-amino-acid extension compared to eIF2γ homologs in higher eukaryotes. In S. cerevisiae this region is required to recruit PPP-1 to eIF2α (45) (see Fig. S3A). We predicted that if the N terminus of N. crassa eIF2γ functions analogously, the levels of P-eIF2α would be high in strains that have an N-terminal eIF2γ deletion. To test this prediction, residues 2 to 62 were deleted from the endogenous eIF2γ gene (here referred to as eIF2γΔ2-62) (see Fig. S3A), and P-eIF2α levels were examined in a circadian time course (Fig. 3). As predicted, removal of this putative phosphatase-recruiting domain resulted in significantly higher P-eIF2α levels in eIF2γΔ2-62 compared to WT cells. Furthermore, P-eIF2α levels in eIF2γΔ2-62 cells were not significantly different than the high levels observed in ppp-1RIP cells (Fig. 3A). These results support a role for the N-terminal region of N. crassa eIF2γ in recruiting PPP-1 phosphatase to P-eIF2α in vivo.
To determine whether the N terminus of eIF2γ impacts dephosphorylation of eIF2α by PPP-1 in vitro, the eIF2 complex was purified from N. crassa eIF2γ::v5 and eIF2γΔ2-62::v5 cells by coimmunoprecipitation with anti-V5 antibody (see Fig. S3B). The eIF2 complex containing pulled down P-eIF2α with eIF2γ::V5 was incubated with total cell extracts (containing PPP-1) from Δcpc-3 cells, and the eIF2 complex pulled down with eIF2γΔ2-62::V5 was incubated with total cell extracts from eIF2γΔ2-62; Δcpc-3 cells (Fig. 3B). Extracts from Δcpc-3 cells led to an ∼50% reduction of P-eIF2α levels after 120 min, consistent with dephosphorylation of P-eIF2α by PPP-1 and the data shown in Fig. 1C. However, extracts from eIF2γΔ2-62; Δcpc-3 cells that lack the N terminus of eIF2γ showed significantly reduced dephosphorylation of P-eIF2α levels compared to extracts from Δcpc-3 cells (Fig. 3B). In eIF2γΔ2-62; Δcpc-3 cells, P-eIF2α levels were reduced up to 20% at 120 min compared to the 0-min time point, suggesting that additional regulatory subunits present in eIF2γΔ2-62; Δcpc-3 extracts may recruit PPP-1 to dephosphorylate P-eIF2α, although less efficiently than eIF2γ. These results, together with the lack of dephosphorylation of P-eIF2α in mutant PPP-1 extracts (Fig. 1C), support the idea that the N terminus of eIF2γ recruits PPP-1 to dephosphorylate eIF2α in N. crassa.
Deletion of the N terminus of eIF2γ disrupts P-eIF2α level rhythms.
To determine whether the N-terminal extension of eIF2γ is essential for circadian clock control of P-eIF2α, the levels of P-eIF2α were examined over a circadian time course in eIF2γΔ2-62 cells. The levels of P-eIF2α increased over time, and P-eIF2α rhythms were severely dampened in eIF2γΔ2-62 cells (Fig. 3C). When the data were detrended to account for the increasing levels of P-eIF2α over time, a rhythm with significantly reduced amplitude and period was detected (see Fig. S4). This dampened P-eIF2α rhythm observed in eIF2γΔ2-62 cells in vivo is consistent with residual PPP-1 phosphatase activity observed in vitro in eIF2γΔ2-62; Δcpc-3 extracts (Fig. 3B). Total eIF2α levels in eIF2γΔ2-62 cells were arrhythmic (Fig. 3D; see also Fig. S4 in the supplemental material). Unlike the short period FRQ::LUC rhythm observed in ppp-1RIP cells (Fig. 2E), the period of FRQ::LUC reporter rhythms was not significantly altered in eIF2γΔ2-62 cells compared to WT cells (Fig. 3E). Therefore, it is likely that a different regulator is used to target PPP-1 to dephosphorylate FRQ. Also, PPP-1 protein levels were still rhythmic in eIF2γΔ2-62 cells, suggesting the mutation did not impact PPP-1 protein expression (see Fig. S4D). Taken together, these data support a role for the N terminus of eIF2γ in recruiting PPP-1 to P-eIF2α and promoting circadian clock control of P-eIF2α levels.
Rhythmic phosphorylation of eIF2α requires rhythmic PPP-1 levels.
PPP-1 phosphatase and the N terminus of eIF2γ are necessary for circadian rhythms of P-eIF2α levels but not for core clock function. Thus, rhythmic control of eIF2α activity may be through clock control of the levels and/or activities of PPP-1 phosphatase and/or eIF2γ. Prior mass spectrometry proteomic studies suggested that PPP-1 protein, but not eIF2γ, could be rhythmic (25). To determine whether the circadian clock controls the levels of PPP-1 phosphatase and/or eIF2γ, PPP-1::luciferase (PPP-1::LUC) and eIF2γ::V5 C-terminal translational fusion constructs were generated and used to replace the corresponding endogenous loci. No change in P-eIF2α levels was observed in cells containing the V5-tagged version of eIF2γ::V5 compared to WT cells, indicating the tag does not alter the function of eIF2γ (see Fig. S5). PPP-1::LUC protein accumulated rhythmically in WT cells but not in control clock mutant Δfrq cells, (Fig. 4A), demonstrating that PPP-1 protein levels are clock-controlled. Consistent with PPP-1 functioning as an eIF2α phosphatase, the early evening peak (with phase CT [circadian time] 14, which corresponds to DD24) in PPP-1::LUC levels correlated with the trough of P-eIF2α levels (see Fig. 2A, DD24). Alternatively, eIF2γ::V5 levels did not cycle in WT cells (Fig. 4B). In addition, PPP-1::LUC rhythmicity was not altered in Δcpc-3 cells that are unable to phosphorylate eIF2α (31) (see Fig. S6), indicating that PPP-1 protein level rhythms arise from mechanisms that are independent of rhythmic eIF2α activity. Together, these data suggested the possibility that the nighttime peak in PPP-1 levels may be critical for P-eIF2α rhythms.
To determine whether rhythmic accumulation of PPP-1 is necessary for rhythms in P-eIF2α levels, protein from strains containing Ptcu-1::ppp-1 (Fig. 1B) grown in a circadian time course were isolated and examined by Western blotting with anti-PPP-1 antibody. In WT cells, PPP-1 protein levels were rhythmic, peaking in the subjective early evening (DD24), consistent with the PPP-1::LUC rhythms (Fig. 5A). In Ptcu1::ppp-1 cells grown in the presence of the activating chelator BCS, PPP-1 levels were high and noncycling (Fig. 1B and 5B), and P-eIF2α levels were low and arrhythmic (Fig. 5C). In Ptcu1::ppp-1 cells grown in the presence of the repressive copper ion (Cu), PPP-1 protein levels were low (Fig. 1B), and P-eIF2α levels were high and arrhythmic (Fig. 5D). Thus, nonrhythmic PPP-1 expression at either low or high levels abolished P-eIF2α rhythms. These data demonstrated that the rhythmic accumulation of PPP-1 protein is necessary for circadian rhythms in P-eIF2α levels.
DISCUSSION
In N. crassa and mice, circadian clock regulation of eIF2α phosphorylation controls rhythmic mRNA translation and protein accumulation (30, 31). In N. crassa the eIF2α kinase, CPC-3, is necessary for the accumulation of P-eIF2α levels and a constitutively active allele causes arrhythmicity of P-eIF2α (31). Here, we show that protein phosphatase PPP-1, which peaks in levels during the subjective night, is also necessary for circadian rhythms in P-eIF2α levels. These data support a model whereby the circadian clock dynamically regulates both the phosphorylation, through the day-stimulated CPC-3 kinase, and dephosphorylation, by the night-peaking PPP-1 phosphatase, of eIF2α (Fig. 5E). The peak in activity of eIF2α at night, together with increased nighttime activity of translation elongation factor eEF-2 (28), provide a mechanism to explain increased rhythmic protein production at night in N. crassa (25).
While PPP-1 is necessary for rhythmic eIF2α activity, it is not sufficient to drive rhythms in P-eIF2α levels in strains with constitutively active CPC-3 (CPC-3C). In cpc-3C cells, P-eIF2α levels are high and arrhythmic (31), despite normal rhythmic PPP-1 levels in the mutant (see Fig. S7 in the supplemental material). This may be due the levels or activity of PPP-1 not being sufficient to dephosphorylate the constantly high levels of P-eIF2α present in this mutant. While we showed that P-eIF2α levels are directly related to PPP-1 levels in a strain with WT CPC-3 activity (Fig. 1B), after 2 h in vitro only up to 50% of P-eIF2α was dephosphorylated by PPP-1 indicating that the dephosphorylation step may be kinetically unfavorable (Fig. 1C). These data are consistent with the slow in vitro dephosphorylation rate of eIF2α observed in yeast extracts (45). A second possibility for why PPP-1 rhythms are not sufficient to drive P-eIF2α rhythms in the cpc-3C mutant is that PPP-1 may also regulate CPC-3 activity. This idea is supported by the presence of at least two phosphatases in S. cerevisiae known to target both P-eIF2α and P-GCN2. The 2A-related phosphatase SIT4, which responds to the Target of Rapamycin (TOR) pathway (54, 55) and dephosphorylates eIF2α (56), also controls Ser577 phosphorylation and activity of GCN2. The phosphatase PPZ1 also impacts GCN2-dependent phosphorylation of eIF2α by an unknown mechanism (57, 58). Thus, in addition to direct dephosphorylation of eIF2α, these data support a role for phosphatases controlling the activity of the eIF2α kinases. Experiments are under way to identify potentially rhythmic phosphorylation sites on CPC-3 that may be dephosphorylated by PPP-1. The presence of WT PPP-1 was necessary for dephosphorylation of P-eIF2α in vitro. Given the residual in vitro phosphatase activity in eIF2γΔ2-62 cells (Fig. 3B), we cannot absolutely rule out that other PPP-1-dependent phosphatases in the extracts perform the dephosphorylation of P-eIF2α. This residual activity may also explain why the rhythms of P-eIF2α levels are severely diminished, and not completely abolished, in eIF2γΔ2-62 cells (see Fig. S4). In any case, our data support that PPP-1 is recruited to P-eIF2α by the eIF2 subunit eIF2γ to directly dephosphorylate P-eIF2α.
Kinases typically target specific substrates; however, phosphatases generally have a wide substrate range (45). In addition to dephosphorylation of eIF2α, S. cerevisiae Glc7, the catalytic subunit of PP1, dephosphorylates substrates that function in glycogen metabolism, glucose regulation, and cell division (59). Furthermore, PP1 requires one or more noncatalytic regulatory subunits to target it to different cellular compartments and for substrate specificity. More than 180 PP1 regulatory subunits have been identified in mammalian cells (60), and 17 regulatory subunits were discovered in S. cerevisiae (61). Most, but not all, PP1 regulatory subunits contain a conserved RVxF motif, which is typically flanked by basic residues at the N terminus, and by acidic residues at the C terminus (62). Regulatory subunits that recruit PP1 to eIF2α in mammalian cells, GADD34 and CReP, contain an RVxF motif (43, 44). In the PP1 regulatory subunit eIF2γ in S. cerevisiae, the RVxF motif is present in an N-terminal domain that extends beyond homology to mammalian eIF2γ (45), and deletion of the N terminus of eIF2γ does not affect yeast cell growth, indicating that the eIF2 complex is functional in translation (63). Although N. crassa eIF2γ lacks the conserved RVxF motif (see Fig. S3A), we show that the N terminus of eIF2γ is important for P-eIF2α levels (Fig. 3A), in vitro dephosphorylation (Fig. 3B), and rhythmicity (Fig. 3C). Because the levels of eIF2γ are not clock-controlled (Fig. 4B), we suggest that the interaction between the eIF2γ and eIF2α in the eIF2 complex provides a platform for eIF2γ to deliver PPP-1 at night, when it is at peak levels under the control of the clock (Fig. 4A). Furthermore, our data support the possibility that interactions between PPP-1 and eIF2, including eIF2γ and eIF2α subunits, as well as CPC-3, may be localized to the ribosome (see Fig. S2C), although additional experiments are needed to confirm this possibility.
Disruption of P-eIF2α rhythms, either by deletion or mutation of CPC-3 kinase in N. crassa, impacts the rhythmic translation of alg-11, but not FRQ (31) or PPP-1 (see Fig. S6) protein rhythms, or overt developmental rhythms (31). These data support that under constant environmental conditions, circadian translational regulation by the rhythmic activity of eIF2α is gene specific, as opposed to a global translational response (31). In ppp-1RIPcells, the period of FRQ::LUC accumulation rhythms is shorter compared to WT cells (47) (Fig. 2E). However, the short period FRQ::LUC rhythm in ppp-1RIP is not due to loss of P-eIF2α rhythms in the mutant because disruption of P-eIF2α rhythms in eIF2γΔ2-62 cells did not significantly alter the period of FRQ::LUC rhythmicity (Fig. 3E).
eIF2α phosphorylation regulates protein production to enable the organism to quickly respond to environmental stresses, including amino acid starvation. The circadian clock provides an additional layer of regulation of eIF2α activity to control the rhythmic translation of specific target genes. While the mechanisms underlying this specificity are not known, these data support the idea that temporal control of eIF2α activity provides organisms, from fungi to mammals, the ability to respond and adapt to internal and environmental stimuli (64). Because mRNA translation requires significant cellular energy, clock control of translation may provide a mechanism to coordinate energy metabolism with translation to partition translation to the times of day when energy levels are high.
MATERIALS AND METHODS
N. crassa strains and growth conditions.
N. crassa vegetative growth conditions, transformation and crossing protocols were as described previously (65). Strains generated for use in this study are described in the supplemental materials and methods (see Text S1) and are listed in Table S1 in the supplemental material. The primers used in the generation and validation strains are listed in Table S2.
Circadian time courses.
Circadian time course experiments for Western blots were done as previously described (65). For constitutive expression of bar::Ptcu-1::ppp-1, cells were grown in Vogel’s medium containing 50 μM the copper chelator bathocuproinedisulfonic acid (BCS, B1125; Sigma-Aldrich, St. Louis, MO) or 250 μM copper sulfate (CuSO4; C7631; Sigma-Aldrich) to control the expression of the tcu-1 promoter (48).
Protein extraction and Western blotting.
Protein extraction, protein concentration, and Western blot analyses were performed as previously described (28). Briefly, tissue was ground in liquid nitrogen with a mortar and pestle, and suspended in extraction buffer containing 100 mM Tris pH 7.0, 1% sodium dodecyl sulfate (SDS), 10 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium ortho-vanadate, 1 mM β-glycerophosphate, 1× aprotinin, 1× leupeptin hemisulfate salt, and 1× pepstatin A. Protein concentration was determined by NanoDrop (Thermo Fisher Scientific, Wilmington, DE). Protein samples (100 μg) were separated on 10% SDS-PAGE gels and blotted to Immobilon-P nitrocellulose membranes (catalog no. IPVH00010; Millipore Sigma, Burlington, MA) according to standard methods.
The levels of P-eIF2α were detected using rabbit monoclonal anti-EIF2S1 (phospho S51) antibody (catalog no. ab32157; Abcam, Cambridge, UK) diluted 1:5000 in 5% bovine serum albumin, 1× Tris-buffered saline (TBS), 0.1% Tween, and anti-rabbit IgG horseradish peroxidase (HRP)-conjugated secondary antibody (catalog no. 1706515; Bio-Rad, Hercules, CA) diluted 1:10,000. Total eIF2α levels were detected using rabbit polyclonal anti-EIF2S1 antibody (catalog no. 47508; Abcam) diluted 1:5,000, and anti-rabbit IgG HRP secondary antibody diluted 1:10,000. eIF2γ::V5 was detected using mouse monoclonal anti-V5 antibody (catalog no. R960-25; Invitrogen, Carlsbad, CA) diluted 1:5,000 in 5% milk, 1× TBS, 0.1% Tween, and anti-mouse IgG HRP-secondary antibody (catalog no. 1706516; Bio-Rad) diluted 1:10,000. PPP-1 was detected using a custom rabbit polyclonal anti-PPP-1 antibody (peptide EVRGSRPGKQVQLLC as antigen; GenScript, Piscataway, NJ) diluted 1:1,000 in 7.5% milk, 1× TBS, 0.1% Tween, and anti-rabbit IgG HRP-secondary antibody diluted 1:10,000. Signals were detected using chemiluminescence SuperSignal West Pico substrate (catalog no. 34077; Thermo Fisher Scientific). Densitometry was performed using NIH ImageJ software (66) and normalized to protein loading using amido black-stained protein.
Expression and purification of PPP-1::His6 protein in E. coli.
To validate the specificity of PPP-1 antibody, the ppp-1 ORF was amplified with the primers PPP-1::His6 F and PPP-1::His6 R containing restriction sites for NdeI and NotI using N. crassa cDNA as the template. The pET30b vector (Invitrogen) and PCR fragment were digested with NdeI and NotI restriction enzymes and then ligated with T7 ligase (NEB). The ligated plasmids were transformed to E. coli DH5α cells and screened by kanamycin resistance and restriction digestion to get an IPTG (isopropyl-β-d-thiogalactopyranoside)-inducible PPP-1::His6 fusion plasmid. The plasmid was transformed into E. coli BL21 cells and grown in 400 ml of Luria-Bertani medium at 37°C with shaking at 250 rpm to an optical density of 0.6. PPP-1::His6 expression was induced by adding 1 mM IPTG 1 h before protein extraction. PPP-1::His6 protein was purified with Ni-NTA column following published methods (67). PPP-1::His6 protein was visualized by Coomassie blue stain and Western blotting with PPP-1 antibody.
In vivo luciferase assays.
Luciferase assays to examine bioluminescence rhythms arising from strains containing luciferase fusions were performed as previously described (28). Briefly, 5 μl of 1 × 105 conidia/ml were inoculated into 96-well microtiter plates containing 150 μl of 1× Vogel’s salts, 0.01% glucose, 0.03% arginine, 0.1 M quinic acid, 1.5% agar, and 25 μM firefly luciferin (LUNCA-300; Gold Biotechnology, St. Louis, MO) (pH 6). After inoculation, the microtiter plate was incubated at 30°C in constant light (LL) for 24 h and transferred to DD 25°C to obtain bioluminescence recordings using an EnVision Xcite Multilabel Reader (Perkin-Elmer Life Science, Boston, MA), with recordings taken every 90 min over at least 5 continuous days. Raw luciferase activity data were analyzed for period using BioDARE (68). Raw reads were normalized to the mean to graph the data.
Statistical analysis.
Circadian time course data were examined using F tests of the fit of the data to a sine wave or a line, as previously described (65, 69). A Student's t-test was used to determine significance in changes in the levels of P-eIF2α and PPP-1. Error bars in all graphs represent the standard errors of the mean (SEM) from at least three independent experiments.
In vitro dephosphorylation assay.
The eIF2 complex was isolated by anti-V5 coimmunoprecipitation from an eIF2γ::V5 and eIF2γΔ2-62::V5 protein extracts. The eIF2 complex was immobilized onto magnetic Dynabeads (catalog no. 10008D; Invitrogen) and washed with 2× phosphatase buffer (100 mM HEPES, 200 mM NaCl, 2 mM dithiothreitol, 2 mM MnCl2, 0.01% Brij-35) (45). Then, 500 μg of protein extracted from Δcpc-3 or ppp-1RIP; Δcpc-3 or eIF2γΔ2-62; Δcpc-3 strains, harvested at DD28, was mixed with 200 μl of the immobilized eIF2-Dynabeads in 2× phosphatase buffer. Reaction mixtures were incubated at 30°C with gentle rotation, and at each time point 48 μl of the reaction mix was transferred to a fresh tube and boiled for 5 min with 16 μl of 4× SDS loading buffer (250 mM [pH 6.8] Tris-Cl, 8% SDS, 0.2% bromophenol blue, 40% glycerol, 20% β-mercaptoethanol) to stop the reaction. P-eIF2α and total eIF2α levels were detected by Western blotting.
Sucrose gradient fractionation.
Linear sucrose gradients (10 to 50% in 10 mM HEPES-KOH, 70 mM ammonium acetate, 5 mM magnesium acetate) were prepared in ultracentrifuge tubes by using a BIOCOMP gradient station (Fredericton, NB, Canada) and stored at 4°C before use. Extracts were prepared by adding polysome extraction buffer (100 mM KCl, 20 mM HEPES-KOH, 10 mM magnesium acetate, 15 mM β-mercaptoethanol, 100 μg/ml cycloheximide) to ground tissues and centrifuging the solution to remove cellular debris and lipids. Next, 400 μl of the extract containing 100 A260 units/ml (1 A260 unit corresponds to an absorbance of 1.0 at 260 nm) was added onto the sucrose gradient and centrifuged at 41,000 rpm for 2h at 4°C. The samples were then divided into 14 fractions of approximately 1 ml each using the BIOCOMP. The absorbances at 260 nm were used as a proxy for RNA content and graphed against the fraction of the gradient. Disome, trisome, tetrasome, and pentosome fractions were pooled as the polysome fraction. Fractions representing the 40S (#4), 60S (#5), 80S (#6) ribosome and the pooled polysome fraction were boiled in SDS loading buffer (250 mM [pH 6.8] Tris-Cl, 8% SDS, 0.2% bromophenol blue, 40% glycerol, 20% β-mercaptoethanol), and 15 μl was separated on a 10% SDS-PAGE gel for Western blotting.
ACKNOWLEDGMENTS
We thank Rachel Stroh for technical assistance with strain construction, Yi Liu for the ppp-1RIP strain, and Qun He for kindly providing PPP-1 antibodies for preliminary Western blot trials. We also thank Thomas Dever and Madhusudan Dey for advice on the in vitro dephosphorylation of eIF2α, and we thank Matthew Sachs and Cheng Wu and members of the Bell-Pedersen lab for helpful discussions.
This study was funded by NIH R01 GM058529 and R35 GM126966 to D.B.-P.
Footnotes
This article is a direct contribution from Deborah Bell-Pedersen, a Fellow of the American Academy of Microbiology, who arranged for and secured reviews by Jay Dunlap, Geisel School of Medicine at Dartmouth, and Yi Liu, UT Southwestern Medical Center.
Citation Ding Z, Lamb TM, Boukhris A, Porter R, Bell-Pedersen D. 2021. Circadian clock control of translation initiation factor eIF2α activity requires eIF2γ-dependent recruitment of rhythmic PPP-1 phosphatase in Neurospora crassa. mBio 12:e00871-21. https://doi.org/10.1128/mBio.00871-21.
Contributor Information
Deborah Bell-Pedersen, Email: dpedersen@bio.tamu.edu.
Reinhard Fischer, Karlsruhe Institute of Technology.
REFERENCES
- 1.Panda S, Hogenesch JB, Kay SA. 2002. Circadian rhythms from flies to human. Nature 417:329–335. doi: 10.1038/417329a. [DOI] [PubMed] [Google Scholar]
- 2.Kondo T, Tsinoremas NF, Golden SS, Johnson CH, Kutsuna S, Ishiura M. 1994. Circadian clock mutants of cyanobacteria. Science 266:1233–1236. doi: 10.1126/science.7973706. [DOI] [PubMed] [Google Scholar]
- 3.Dunlap JC, Loros JJ. 2004. The Neurospora circadian system. J Biol Rhythms 19:414–424. doi: 10.1177/0748730404269116. [DOI] [PubMed] [Google Scholar]
- 4.Sharma VK. 2003. Adaptive significance of circadian clocks. Chronobiol Int 20:901–919. doi: 10.1081/cbi-120026099. [DOI] [PubMed] [Google Scholar]
- 5.Bell-Pedersen D, Cassone VM, Earnest DJ, Golden SS, Hardin PE, Thomas TL, Zoran MJ. 2005. Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet 6:544–556. doi: 10.1038/nrg1633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dunlap JC. 1999. Molecular bases for circadian clocks. Cell 96:271–290. doi: 10.1016/s0092-8674(00)80566-8. [DOI] [PubMed] [Google Scholar]
- 7.Hall JC. 1998. Genetics of biological rhythms in Drosophila. Adv Genet 38:135–184. doi: 10.1016/s0065-2660(08)60143-1. [DOI] [PubMed] [Google Scholar]
- 8.Young MW. 1998. The molecular control of circadian behavioral rhythms and their entrainment in Drosophila. Annu Rev Biochem 67:135–152. doi: 10.1146/annurev.biochem.67.1.135. [DOI] [PubMed] [Google Scholar]
- 9.Partch CL, Green CB, Takahashi JS. 2014. Molecular architecture of the mammalian circadian clock. Trends Cell Biol 24:90–99. doi: 10.1016/j.tcb.2013.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Nohales MA, Kay SA. 2016. Molecular mechanisms at the core of the plant circadian oscillator. Nat Struct Mol Biol 23:1061–1069. doi: 10.1038/nsmb.3327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Koike N, Yoo SH, Huang HC, Kumar V, Lee C, Kim TK, Takahashi JS. 2012. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science 338:349–354. doi: 10.1126/science.1226339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Menet JS, Rodriguez J, Abruzzi KC, Rosbash M. 2012. Nascent-Seq reveals novel features of mouse circadian transcriptional regulation. Elife 1:e00011. doi: 10.7554/eLife.00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Duffield GE. 2003. DNA microarray analyses of circadian timing: the genomic basis of biological time. J Neuroendocrinol 15:991–1002. doi: 10.1046/j.1365-2826.2003.01082.x. [DOI] [PubMed] [Google Scholar]
- 14.Nagel DH, Kay SA. 2012. Complexity in the wiring and regulation of plant circadian networks. Curr Biol 22:R648–R657. doi: 10.1016/j.cub.2012.07.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hurley JM, Dasgupta A, Emerson JM, Zhou X, Ringelberg CS, Knabe N, Lipzen AM, Lindquist EA, Daum CG, Barry KW, Grigoriev IV, Smith KM, Galagan JE, Bell-Pedersen D, Freitag M, Cheng C, Loros JJ, Dunlap JC. 2014. Analysis of clock-regulated genes in Neurospora reveals widespread posttranscriptional control of metabolic potential. Proc Natl Acad Sci U S A 111:16995–17002. doi: 10.1073/pnas.1418963111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Vitalini MW, de Paula RM, Park WD, Bell-Pedersen D. 2006. The rhythms of life: circadian output pathways in Neurospora. J Biol Rhythms 21:432–444. doi: 10.1177/0748730406294396. [DOI] [PubMed] [Google Scholar]
- 17.Vollmers C, Schmitz RJ, Nathanson J, Yeo G, Ecker JR, Panda S. 2012. Circadian oscillations of protein-coding and regulatory RNAs in a highly dynamic mammalian liver epigenome. Cell Metab 16:833–845. doi: 10.1016/j.cmet.2012.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Fustin J-M, Doi M, Yamaguchi Y, Hida H, Nishimura S, Yoshida M, Isagawa T, Morioka MS, Kakeya H, Manabe I, Okamura H. 2013. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell 155:793–806. doi: 10.1016/j.cell.2013.10.026. [DOI] [PubMed] [Google Scholar]
- 19.Belanger V, Picard N, Cermakian N. 2006. The circadian regulation of Presenilin-2 gene expression. Chronobiol Int 23:747–766. doi: 10.1080/07420520600827087. [DOI] [PubMed] [Google Scholar]
- 20.Baggs JE, Green CB. 2003. Nocturnin, a deadenylase in Xenopus laevis retina: a mechanism for posttranscriptional control of circadian-related mRNA. Curr Biol 13:189–198. doi: 10.1016/s0960-9822(03)00014-9. [DOI] [PubMed] [Google Scholar]
- 21.Lipton JO, Yuan ED, Boyle LM, Ebrahimi-Fakhari D, Kwiatkowski E, Nathan A, Guttler T, Davis F, Asara JM, Sahin M. 2015. The circadian protein BMAL1 regulates translation in response to S6K1-mediated phosphorylation. Cell 161:1138–1151. doi: 10.1016/j.cell.2015.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Robles MS, Cox J, Mann M. 2014. In-vivo quantitative proteomics reveals a key contribution of posttranscriptional mechanisms to the circadian regulation of liver metabolism. PLoS Genet 10:e1004047. doi: 10.1371/journal.pgen.1004047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Mauvoisin D, Wang J, Jouffe C, Martin E, Atger F, Waridel P, Quadroni M, Gachon F, Naef F. 2014. Circadian clock-dependent and -independent rhythmic proteomes implement distinct diurnal functions in mouse liver. Proc Natl Acad Sci U S A 111:167–172. doi: 10.1073/pnas.1314066111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Reddy AB, Karp NA, Maywood ES, Sage EA, Deery M, O’Neill JS, Wong GK, Chesham J, Odell M, Lilley KS, Kyriacou CP, Hastings MH. 2006. Circadian orchestration of the hepatic proteome. Curr Biol 16:1107–1115. doi: 10.1016/j.cub.2006.04.026. [DOI] [PubMed] [Google Scholar]
- 25.Hurley JM, Jankowski MS, De Los Santos H, Crowell AM, Fordyce SB, Zucker JD, Kumar N, Purvine SO, Robinson EW, Shukla A, Zink E, Cannon WR, Baker SE, Loros JJ, Dunlap JC. 2018. Circadian proteomic analysis uncovers mechanisms of posttranscriptional regulation in metabolic pathways. Cell Syst 7:613–626 e5. doi: 10.1016/j.cels.2018.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Cao R, Gkogkas CG, de Zavalia N, Blum ID, Yanagiya A, Tsukumo Y, Xu H, Lee C, Storch KF, Liu AC, Amir S, Sonenberg N. 2015. Light-regulated translational control of circadian behavior by eIF4E phosphorylation. Nat Neurosci 18:855–862. doi: 10.1038/nn.4010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Jouffe C, Cretenet G, Symul L, Martin E, Atger F, Naef F, Gachon F. 2013. The circadian clock coordinates ribosome biogenesis. PLoS Biol 11:e1001455. doi: 10.1371/journal.pbio.1001455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Caster SZ, Castillo K, Sachs MS, Bell-Pedersen D. 2016. Circadian clock regulation of mRNA translation through eukaryotic elongation factor eEF-2. Proc Natl Acad Sci U S A 113:9605–9610. doi: 10.1073/pnas.1525268113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wang R, Jiang X, Bao P, Qin M, Xu J. 2019. Circadian control of stress granules by oscillating EIF2α. Cell Death Dis 10:215. doi: 10.1038/s41419-019-1471-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Pathak SS, Liu D, Li T, de Zavalia N, Zhu L, Li J, Karthikeyan R, Alain T, Liu AC, Storch KF, Kaufman RJ, Jin VX, Amir S, Sonenberg N, Cao R. 2019. The eIF2α kinase GCN2 modulates period and rhythmicity of the circadian clock by translational control of Atf4. Neuron 104:724–735 e6. doi: 10.1016/j.neuron.2019.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Karki S, Castillo K, Ding Z, Kerr O, Lamb TM, Wu C, Sachs MS, Bell-Pedersen D. 2020. Circadian clock control of eIF2α phosphorylation is necessary for rhythmic translation initiation. Proc Natl Acad Sci U S A 117:10935–10945. doi: 10.1073/pnas.1918459117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hinnebusch AG, Lorsch JR. 2012. The mechanism of eukaryotic translation initiation: new insights and challenges. Cold Spring Harb Perspect Biol 4:a011544. doi: 10.1101/cshperspect.a011544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sonenberg N, Hinnebusch AG. 2009. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136:731–745. doi: 10.1016/j.cell.2009.01.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wei J, Zhang Y, Ivanov IP, Sachs MS. 2013. The stringency of start codon selection in the filamentous fungus Neurospora crassa. J Biol Chem 288:9549–9562. doi: 10.1074/jbc.M112.447177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hinnebusch AG. 2017. Structural insights into the mechanism of scanning and start codon recognition in eukaryotic translation initiation. Trends Biochem Sci 42:589–611. doi: 10.1016/j.tibs.2017.03.004. [DOI] [PubMed] [Google Scholar]
- 36.Dever TE, Feng L, Wek RC, Cigan AM, Donahue TF, Hinnebusch AG. 1992. Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast. Cell 68:585–596. doi: 10.1016/0092-8674(92)90193-g. [DOI] [PubMed] [Google Scholar]
- 37.Proud CG. 2005. eIF2 and the control of cell physiology. Semin Cell Dev Biol 16:3–12. doi: 10.1016/j.semcdb.2004.11.004. [DOI] [PubMed] [Google Scholar]
- 38.Chesnokova E, Bal N, Kolosov P. 2017. Kinases of eIF2a switch translation of mRNA subsets during neuronal plasticity. Int J Mol Sci 18:2213. doi: 10.3390/ijms18102213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Castilho BA, Shanmugam R, Silva RC, Ramesh R, Himme BM, Sattlegger E. 2014. Keeping the eIF2α kinase Gcn2 in check. Biochim Biophys Acta 1843:1948–1968. doi: 10.1016/j.bbamcr.2014.04.006. [DOI] [PubMed] [Google Scholar]
- 40.Wek RC, Cannon JF, Dever TE, Hinnebusch AG. 1992. Truncated protein phosphatase GLC7 restores translational activation of GCN4 expression in yeast mutants defective for the eIF-2α kinase GCN2. Mol Cell Biol 12:5700–5710. doi: 10.1128/mcb.12.12.5700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Connor JH, Weiser DC, Li S, Hallenbeck JM, Shenolikar S. 2001. Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. Mol Cell Biol 21:6841–6850. doi: 10.1128/MCB.21.20.6841-6850.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Cohen PT. 2002. Protein phosphatase 1–targeted in many directions. J Cell Sci 115:241–256. https://journals.biologists.com/jcs/article/115/2/241/34770/Protein-phosphatase-1-targeted-in-many-directions. [DOI] [PubMed] [Google Scholar]
- 43.Harding HP, Zhang Y, Scheuner D, Chen JJ, Kaufman RJ, Ron D. 2009. Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2α) dephosphorylation in mammalian development. Proc Natl Acad Sci U S A 106:1832–1837. doi: 10.1073/pnas.0809632106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Brush MH, Weiser DC, Shenolikar S. 2003. Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1α to the endoplasmic reticulum and promotes dephosphorylation of the α subunit of eukaryotic translation initiation factor 2. Mol Cell Biol 23:1292–1303. doi: 10.1128/mcb.23.4.1292-1303.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rojas M, Gingras AC, Dever TE. 2014. Protein phosphatase PP1/GLC7 interaction domain in yeast eIF2γ bypasses targeting subunit requirement for eIF2α dephosphorylation. Proc Natl Acad Sci U S A 111:E1344–E1353. doi: 10.1073/pnas.1400129111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Ghosh A, Servin JA, Park G, Borkovich KA. 2014. Global analysis of serine/threonine and tyrosine protein phosphatase catalytic subunit genes in Neurospora crassa reveals interplay between phosphatases and the p38 mitogen-activated protein kinase. G3 (Bethesda) 4:349–365. doi: 10.1534/g3.113.008813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Yang Y, He Q, Cheng P, Wrage P, Yarden O, Liu Y. 2004. Distinct roles for PP1 and PP2A in the Neurospora circadian clock. Genes Dev 18:255–260. doi: 10.1101/gad.1152604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Lamb TM, Vickery J, Bell-Pedersen D. 2013. Regulation of gene expression in Neurospora crassa with a copper responsive promoter. G3 (Bethesda) 3:2273–2280. doi: 10.1534/g3.113.008821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Ramirez M, Wek RC, Hinnebusch AG. 1991. Ribosome association of GCN2 protein kinase, a translational activator of the GCN4 gene of Saccharomyces cerevisiae. Mol Cell Biol 11:3027–3036. doi: 10.1128/mcb.11.6.3027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Garcia-Barrio M, Dong J, Ufano S, Hinnebusch AG. 2000. Association of GCN1-GCN20 regulatory complex with the N terminus of eIF2α kinase GCN2 is required for GCN2 activation. EMBO J 19:1887–1899. doi: 10.1093/emboj/19.8.1887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Marton MJ, Crouch D, Hinnebusch AG. 1993. GCN1, a translational activator of GCN4 in Saccharomyces cerevisiae, is required for phosphorylation of eukaryotic translation initiation factor 2 by protein kinase GCN2. Mol Cell Biol 13:3541–3556. doi: 10.1128/mcb.13.6.3541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Sattlegger E, Hinnebusch AG. 2000. Separate domains in GCN1 for binding protein kinase GCN2 and ribosomes are required for GCN2 activation in amino acid-starved cells. EMBO J 19:6622–6633. doi: 10.1093/emboj/19.23.6622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Vazquez de Aldana CR, Marton MJ, Hinnebusch AG. 1995. GCN20, a novel ATP binding cassette protein, and GCN1 reside in a complex that mediates activation of the eIF-2α kinase GCN2 in amino acid-starved cells. EMBO J 14:3184–3199. doi: 10.1002/j.1460-2075.1995.tb07321.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Garcia-Barrio M, Dong J, Cherkasova VA, Zhang X, Zhang F, Ufano S, Lai R, Qin J, Hinnebusch AG. 2002. Serine 577 is phosphorylated and negatively affects the tRNA binding and eIF2α kinase activities of GCN2. J Biol Chem 277:30675–30683. doi: 10.1074/jbc.M203187200. [DOI] [PubMed] [Google Scholar]
- 55.Cherkasova VA, Hinnebusch AG. 2003. Translational control by TOR and TAP42 through dephosphorylation of eIF2α kinase GCN2. Genes Dev 17:859–872. doi: 10.1101/gad.1069003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Cherkasova V, Qiu H, Hinnebusch AG. 2010. Snf1 promotes phosphorylation of the α subunit of eukaryotic translation initiation factor 2 by activating Gcn2 and inhibiting phosphatases Glc7 and Sit4. Mol Cell Biol 30:2862–2873. doi: 10.1128/MCB.00183-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Calafi C, Lopez-Malo M, Velazquez D, Zhang C, Fernandez-Fernandez J, Rodriguez-Galan O, de la Cruz J, Arino J, Casamayor A. 2020. Overexpression of budding yeast protein phosphatase Ppz1 impairs translation. Biochim Biophys Acta Mol Cell Res 1867:118727. doi: 10.1016/j.bbamcr.2020.118727. [DOI] [PubMed] [Google Scholar]
- 58.Velazquez D, Albacar M, Zhang C, Calafi C, Lopez-Malo M, Torres-Torronteras J, Marti R, Kovalchuk SI, Pinson B, Jensen ON, Daignan-Fornier B, Casamayor A, Arino J. 2020. Yeast Ppz1 protein phosphatase toxicity involves the alteration of multiple cellular targets. Sci Rep 10:15613. doi: 10.1038/s41598-020-72391-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Stark MJ. 1996. Yeast protein serine/threonine phosphatases: multiple roles and diverse regulation. Yeast 12:1647–1675. doi:. [DOI] [PubMed] [Google Scholar]
- 60.Heroes E, Lesage B, Gornemann J, Beullens M, Van Meervelt L, Bollen M. 2013. The PP1 binding code: a molecular-lego strategy that governs specificity. FEBS J 280:584–595. doi: 10.1111/j.1742-4658.2012.08547.x. [DOI] [PubMed] [Google Scholar]
- 61.Cannon JF. 2010. Function of protein phosphatase-1, Glc7, in Saccharomyces cerevisiae. Adv Appl Microbiol 73:27–59. doi: 10.1016/S0065-2164(10)73002-1. [DOI] [PubMed] [Google Scholar]
- 62.Wakula P, Beullens M, Ceulemans H, Stalmans W, Bollen M. 2003. Degeneracy and function of the ubiquitous RVXF motif that mediates binding to protein phosphatase-1. J Biol Chem 278:18817–18823. doi: 10.1074/jbc.M300175200. [DOI] [PubMed] [Google Scholar]
- 63.Erickson FL, Harding LD, Dorris DR, Hannig EM. 1997. Functional analysis of homologs of translation initiation factor 2 gamma in yeast. Mol Gen Genet 253:711–719. doi: 10.1007/s004380050375. [DOI] [PubMed] [Google Scholar]
- 64.Jackson RJ, Hellen CU, Pestova TV. 2010. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11:113–127. doi: 10.1038/nrm2838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Lamb TM, Goldsmith CS, Bennett L, Finch KE, Bell-Pedersen D. 2011. Direct transcriptional control of a p38 MAPK pathway by the circadian clock in Neurospora crassa. PLoS One 6:e27149. doi: 10.1371/journal.pone.0027149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675. doi: 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Liu H, Naismith JH. 2009. A simple and efficient expression and purification system using two newly constructed vectors. Protein Expr Purif 63:102–111. doi: 10.1016/j.pep.2008.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Zielinski T, Moore AM, Troup E, Halliday KJ, Millar AJ. 2014. Strengths and limitations of period estimation methods for circadian data. PLoS One 9:e96462. doi: 10.1371/journal.pone.0096462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Bennett LD, Beremand P, Thomas TL, Bell-Pedersen D. 2013. Circadian activation of the mitogen-activated protein kinase MAK-1 facilitates rhythms in clock-controlled genes in Neurospora crassa. Eukaryot Cell 12:59–69. doi: 10.1128/EC.00207-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.